Melissa A. Burgess, MD (she/her/hers)

-
University of Pittsburgh Medical Center Hillman Cancer Center
Pittsburgh, Pennsylvania, United States

Disclosure information not submitted.

Presentation(s):

• Paper 36 - PEMBROLIZUMAB MODULATION OF THE EWING TUMOR MICROENVIRONMENT: AN ANALYSIS OF SARC028 PRE/POST TREATMENT EWING SARCOMA BIOPSY SAMPLES

  Friday, November 3, 2023
  10:00 AM – 11:00 AM  

• Paper 62 - PEAK STUDY: A PHASE 3, RANDOMIZED, OPEN-LABEL MULTICENTER CLINICAL STUDY OF BEZUCLASTINIB (CGT9486) AND SUNITINIB COMBINATION VERSUS SUNITINIB IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)

  Saturday, November 4, 2023
  9:00 AM – 10:00 AM  

• Paper 84 - A PHASE 2 STUDY OF ROGARATINIB (BAY 1163877) IN SOFT TISSUE SARCOMAS: INITIAL RESULTS IN COHORT OF PATIENTS WITH SUCCINATE DEHYDROGENASE (SDH)-DEFICIENT GASTROINTESTINAL STROMAL TUMOR (GIST)

  Saturday, November 4, 2023
  3:00 PM – 4:00 PM